Intragastric Injection of Botulinum Toxin A for the Treatment of Obesity
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Botulinum toxin A (BTX-A) is a powerful and long-acting inhibitor of muscular contractions in both striated and smooth muscles. Hypothetically, BTX-A should inhibit the acetylcholine-mediated peristalsis, which is mainly responsible for gastric motility, and thereby induce slowed gastric emptying, earlier satiety and weight loss. The aim of this study was to observe the effects of endoscopic intragastric injections of BTX-A in obese patients.
After approval by the University Ethics Committee, 10 female patients with class I obesity (body mass index 30–35) were double-blind randomized into 2 groups (BTX-A and 0.9% Saline). In Group 1, 200 U BTX-A were injected endoscopically into the antrum and the distal gastric body. In Group 2, 0.9% saline was injected endoscopically into the antrum and the distal gastric body. Body weight and feeling of satiety were recorded monthly over a period of 6 months.
Both groups (BTX-A and 0.9% Saline) showed no significant weight reduction (P > 0.05). One patient in Group 1 and two patients in Group 2 reported a feeling of early satiety. No adverse effects related to BTX-A or complications resulting from the endoscopic procedure were observed.
Intragastric injection of BTX-A for the treatment of obesity does not seem to reduce body weight.
- Intragastric Injection of Botulinum Toxin A for the Treatment of Obesity
Volume 17, Issue 6 , pp 732-736
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- botulinum toxin A
- intragastric injection
- weight loss
- Industry Sectors
- Author Affiliations
- 1. Department of General and Transplant Surgery, University Hospital, Medical University Innsbruck, Innsbruck, Austria
- 4. Department of General and Transplant Surgery, Medical University Innsbruck, Anichstrasse 35, A – 6020, Innsbruck, Austria
- 2. Department of Anesthesia and Intensive Care Medicine, University Hospital, Medical University Innsbruck, Innsbruck, Austria
- 3. Department of Surgery and Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, USA